October Pharma S.A.E (EGX:OCPH)

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceuticals	1.23B	1.01B	727.37M	655.04M	543.40M
Pharmaceuticals Growth	21.39%	39.08%	11.04%	20.54%	3.88%
Total	1.23B	1.01B	727.37M	655.04M	543.40M
Total Growth	21.39%	39.08%	11.04%	20.54%	3.88%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Egypt	1.14B	933.25M	-	-	-
Egypt Growth	22.03%	-	-	-	-
Export	89.23M	78.40M	-	-	-
Export Growth	13.82%	-	-	-	-
Total	1.23B	1.01B	-	-	-
Total Growth	21.39%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error